about
U.S. Government engagement in support of global disease surveillance.Development of vaccines toward the global control and eradication of foot-and-mouth disease.New vaccines needed for pathogens infecting animals and humans: One Health.Using genomics to identify novel antimicrobials.Global Foot-and-Mouth Disease Research Update and Gap Analysis: 7 - Pathogenesis and Molecular Biology.Global Foot-and-Mouth Disease Research Update and Gap Analysis: 6 - Immunology.Global Foot-and-Mouth Disease Research Update and Gap Analysis: 5 - Biotherapeutics and Disinfectants.Global Foot-and-Mouth Disease Research Update and Gap Analysis: 4 - Diagnostics.Global Foot-and-Mouth Disease Research Update and Gap Analysis: 3 - Vaccines.Global Foot-and-Mouth Disease Research Update and Gap Analysis: 2 - Epidemiology, Wildlife and Economics.Global Foot-and-Mouth Disease Research Update and Gap Analysis: 1 - Overview of Global Status and Research Needs.Orbiviruses: A North American Perspective.Comparison of three different leptospiral vaccines for induction of a type 1 immune response to Leptospira borgpetersenii serovar Hardjo.Orbiviruses: A Gap Analysis.Regulatory pathways to enable the licencing of alternatives to antibiotics.Advances in immunology and vaccine discovery report of the United States-European Commission workshop.An outbreak of gangrenous dermatitis in commercial broiler chickens.Vaccines as alternatives to antibiotics for food producing animals. Part 1: challenges and needsVaccines as alternatives to antibiotics for food producing animals. Part 2: new approaches and potential solutionsInnovative drugs, chemicals, and enzymes within the animal production chainBacillus spp. as direct-fed microbial antibiotic alternatives to enhance growth, immunity, and gut health in poultryMicrobial-derived products as potential new antimicrobialsPhytochemicals as antibiotic alternatives to promote growth and enhance host healthAlternatives to antibiotics: a symposium on the challenges and solutions for animal productionA Risk Analysis Model for Experimental Veterinary VaccinesRegulated expression of PDGF A-chain mRNA in human saphenous vein smooth muscle cells
P50
Q33766812-DC97DEA8-72CF-4DEF-B7FD-B0A2060397AFQ37857258-A36FBBFE-6D99-498E-8AE1-3BCA7715B6B1Q38000986-5AA5F508-F03E-49BD-917A-8F161A1D1A38Q38842673-23F82909-B601-4333-B876-538A4063F100Q38851202-0665D9DE-0587-4CB5-A25D-35EF9C80F64FQ38851205-99CAD4A1-0E2D-4044-BB8C-17FFB0B0F5ACQ38851209-4E4551AF-AA85-4746-9372-302A17C6FE4EQ38851213-C3C6C41B-2747-4994-A437-1D336D7B5F41Q38851217-3AED5C84-9B0F-48B1-B9E7-DFB9C4783C50Q38851221-5022A4E2-8BDE-4FF0-B1CE-B8F8A9FBA0E4Q38869889-0CF3AA78-0FC7-486F-BDE4-97B83BA25228Q41153222-1BA908F8-7D1F-489F-A77E-7F103C247656Q43217496-2665B652-F348-4690-BDEC-7417A5AB3B80Q51006244-9B60BC77-8DC0-4AF0-BAC9-0E85C30D720FQ52334169-7882117F-A713-41A9-B6FA-B2E52991A7A4Q52581579-E1D7DDCB-6B80-4641-812E-73CE743A2EB0Q54415689-D6BA5089-627F-4DFB-847D-43CE87AB9C82Q56892169-F25DFA28-C923-49A2-BA93-977146C3E008Q56892183-5E8A9092-9C7B-45B3-8D2B-5351668CE389Q57174065-B14512E1-3BB0-4E51-96D0-C7F827FFC357Q57865458-D303F3EC-F2FA-411F-B26D-82343F0D4466Q57865591-14BAF275-298A-49D9-96CF-1E43277C9F98Q57865609-CC11A9ED-724A-4C1D-8D51-9DA9C982EEEEQ57865823-FBE18315-8BCF-471C-B485-B49C28D49CD4Q57865975-8C371B5B-D79A-4FD6-9418-38C557537934Q57866038-CC35BE11-A70C-430B-9EBE-6A44EF8475EC
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Cyril Gay
@ast
Cyril Gay
@en
Cyril Gay
@es
Cyril Gay
@nl
type
label
Cyril Gay
@ast
Cyril Gay
@en
Cyril Gay
@es
Cyril Gay
@nl
prefLabel
Cyril Gay
@ast
Cyril Gay
@en
Cyril Gay
@es
Cyril Gay
@nl
P106
P1153
55618910300
P31
P496
0000-0002-1685-9114